HONG KONG — Hong Kong authorities said on Thursday they would resume the use of BioNTech’s COVID-19 vaccine next Monday after abruptly halting inoculations nine days ago due to defective packaging.
A 300,000-dose batch is due to arrive in Hong Kong on Friday that was produced and packaged at a different plant to the two batches whose use was halted by authorities.
The announcement comes as the city’s government seeks to convince residents to get vaccinated after a sluggish take-up due to dwindling confidence in a rival vaccine from China’s Sinovac and fears of adverse reactions.
“We want to enhance public confidence in the vaccine program,” Patrick Nip, secretary for the C…
Keep on reading: Hong Kong to resume use of BioNTech COVID-19 vaccines on April 5